Skip to main content

1744 Pill - white capsule/oblong

Pill with imprint 1744 is White, Capsule/Oblong and has been identified as Dasatinib 80 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Dasatinib is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Dasatinib 80 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1744

Dasatinib 80 mg 1744

Dasatinib

Imprint
1744
Strength
80 mg
Color
White (white to off-white)
Shape
Capsule/Oblong (oblong, film-coated)
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
National Drug Code (NDC)
70710-1744

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.